诱导放化疗对肺癌肺叶切除术后肺功能的影响
本研究为回顾性匹配队列研究,采用单光子发射计算机断层扫描肺灌注显像,比较接受与未接受诱导放化疗的肺癌患者肺叶切除术后全肺及区域肺功能的变化。匹配后每组46例,诱导放化疗组术后全肺功能及同侧保留肺叶功能显著低于非诱导组,对侧肺功能增加两组无显著差异。
要点
- 诱导放化疗组肺叶切除术后全肺功能较非诱导组显著降低(P < .001)。
- 同侧保留肺叶术前功能两组无差异(P = .33),术后诱导组显著低于非诱导组(P < .001)。
- 两组对侧肺功能术后均显著增加(P < .01),但组间增加无显著差异(P = .81)。
核心结论
- 诱导放化疗与肺叶切除术后肺功能降低相关,原因是同侧保留肺叶功能下降,可能由诱导放化疗的慢性效应所致。
研究设计与样本
- 回顾性匹配队列研究,连续收集数据。
- 诱导治疗组72例,非诱导治疗组170例,均在肺叶切除术前及术后6个月行肺功能检查和灌注显像。
- 按切除肺叶部位精确匹配后,采用倾向性评分对年龄、吸烟状态、术前肺功能及预测术后肺功能进行匹配,每组各选46例。
- 匹配后5个匹配变量的标准化均数差均<0.1。
主要发现
- 诱导治疗组肺叶切除术后全肺功能较非诱导治疗组显著降低(P < .001)。
- 同侧保留肺叶术前功能两组无差异(P = .33),术后诱导治疗组显著低于非诱导治疗组(P < .001)。
- 两组对侧肺功能术后均显著增加(P < .01),但组间增加无显著差异(P = .81)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Our study aim was to determine whether there are differential changes in whole-lung and regional lung functions after lobectomy for lung cancer between propensity score-matched patients treated with and without induction chemoradiotherapy, by using single-photon emission computed tomography lung perfusion. METHODS: This study was a retrospective matched cohort study of consecutively acquired data. Pulmonary function test and perfusion scintigraphy were conducted before lobectomy and 6 months after lobectomy in patients treated with induction therapy (n = 72) and in those not treated (n = 170), for measuring functional changes of whole lung, contralateral lung, and lobes. After exact matching on resected lobe site, propensity scores for age, smoking status, preoperative pulmonary functions, and predicted postoperative pulmonary function were used to match the groups. RESULTS: After the matching, 46 patients were selected from the groups. Standardized mean differences of the 5 matched variables were <0.1. Whole lung function significantly decreased after lobectomy in the induction therapy group than in the noninduction therapy group (P < .001). Although ipsilateral preserved lobe function before surgery was not different between the groups (P = .33), postoperative value was significantly lower in the induction therapy group than in the noninduction therapy group (P < .001). Although both groups showed a significant increase of contralateral lung function after lobectomy (P < .01), the increases were not significantly different between the groups (P = .81). CONCLUSIONS: Induction chemoradiotherapy was associated with reduced pulmonary function after lobectomy because of a decrease in ipsilateral preserved lobe function, which could be caused by the chronic effects of the induction chemoradiotherapy.
引用
- Nomori H, Shiraishi A, Cong Y, et al. Impact of induction chemoradiotherapy on pulmonary function after lobectomy for lung cancer. J Thorac Cardiovasc Surg. 2017. PMID: 29395208. doi:10.1016/j.jtcvs.2017.12.081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。